Information Library
Results for: Market Access - Market Access Implementation
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Franchise Influence and Leverage Mapping
Brochure — November 10, 2011
In this industry it’s not just whom you know, but who knows you and how far their sphere of influence reaches. -
How Informative is Your Segmentation?
Hear from the Experts — September 15, 2011
Article published by Quintiles' Pieter Sheth-Voss in the Winter 2010 issue of Market Research magazine was recently awarded the David K. Hardin Memorial Award for 2011. -
Executive Vision Forum 2010: Convergence of Stakeholders
Presentation — July 9, 2010
A Holistic Approach to Patient Outcomes - Brian Sweet, CPO, WellPoint. Presentation about the convergence of stakeholders. -
Executive Vision Forum 2010: Clinical and Commercial Convergence
Presentation — July 8, 2010
Pasquale Cetera, VP Portfolio Management, Merck, presentation about the convergence of Clinical and Commercial. -
Defining Value
Brochure — June 8, 2010
Market Access, one of the many Consulting services available from Quintiles, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to winning a preferred position on payer formularies and negotiating pricing and reimbursement contracts. -
Vital Insights
Case Study — June 8, 2010
Quintiles conducted an exhaustive analysis into global and U.S. responses to the use of comparative effectiveness research, identifying key signals to help the customer recognize risk scenarios. -
Bridging Cultures
Case Study — May 9, 2010
Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise. -
PharmAsia News Article Reprint
Media Coverage — March 1, 2010
Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.
Page 1 of 1 (8 results)